Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by Chinese Pulmonary Vascular Disease Research Group
Sponsor:
Information provided by (Responsible Party):
Chinese Pulmonary Vascular Disease Research Group
ClinicalTrials.gov Identifier:
NCT02214043
First received: February 3, 2014
Last updated: August 11, 2014
Last verified: August 2014
  Purpose

There are no special clinical characteristics of acute pulmonary embolism in Chinese population.


Condition
Pulmonary Embolism

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 5 Years
Official Title: Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population

Resource links provided by NLM:


Further study details as provided by Chinese Pulmonary Vascular Disease Research Group:

Primary Outcome Measures:
  • The primary end point of the present study was symptomatic, objectively confirmed recurrent fatal or nonfatal VTE. [ Time Frame: 60 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The second end point was death (all cause death and PE-related death). [ Time Frame: 60 months ] [ Designated as safety issue: No ]
    If the participant died, the relatives need provided the written medical record on the death.


Biospecimen Retention:   Samples Without DNA

BNP,D-dimer


Estimated Enrollment: 600
Study Start Date: January 2012
Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)
Groups/Cohorts
Group 2
group 1

  Eligibility

Ages Eligible for Study:   15 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Acute pulmonary embolism in Chinese population

Criteria

Inclusion Criteria:

  • the symptomatic acute PE confirmed by objective examination

Exclusion Criteria:

  • congestive heart failure
  • chronic obstructive pulmonary disease;
  • a prior documented episode of PE or DVT
  • renal dysfunction;
  • a life expectancy of less than 6 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02214043

Contacts
Contact: Zhihong Liu, Doctor 8601088396590 Zhihongliufuwai@163.com

Locations
China
Center of pumonary vascular diseases Recruiting
Beijing, China, 100037
Contact: Zhihong Liu, doctor    8601088396591    zhihongliufuwai@163.com   
Sponsors and Collaborators
Chinese Pulmonary Vascular Disease Research Group
  More Information

No publications provided

Responsible Party: Chinese Pulmonary Vascular Disease Research Group
ClinicalTrials.gov Identifier: NCT02214043     History of Changes
Other Study ID Numbers: APEINCP
Study First Received: February 3, 2014
Last Updated: August 11, 2014
Health Authority: China: Ministry of Health

Additional relevant MeSH terms:
Embolism
Pulmonary Embolism
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on September 14, 2014